{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:20:19Z","timestamp":1793413219739,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00198-025-07628-5","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:22:09Z","timestamp":1755858129000},"page":"1495-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-2512","authenticated-orcid":false,"given":"Nicholas C.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-1725","authenticated-orcid":false,"given":"Nasser","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-5303","authenticated-orcid":false,"given":"Charlotte","family":"Beaudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nansa","family":"Burlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-9301","authenticated-orcid":false,"given":"Claudia","family":"Campusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-0709","authenticated-orcid":false,"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Halbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ter\u00e9za","family":"Hough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marise","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-9399","authenticated-orcid":false,"given":"Radmila","family":"Matijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0822-3212","authenticated-orcid":false,"given":"Ambrish","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-835X","authenticated-orcid":false,"given":"Ngozi","family":"Njeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-422X","authenticated-orcid":false,"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3129-4326","authenticated-orcid":false,"given":"John A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-6750","authenticated-orcid":false,"given":"Kate","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-8140","authenticated-orcid":false,"given":"Eugene","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"7628_CR1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-016-3894-y","volume":"28","author":"NC Harvey","year":"2017","unstructured":"Harvey NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster JY, Rizzoli R, Cooper C, Kanis JA (2017) Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 28:1507\u20131529","journal-title":"Osteoporos Int"},{"key":"7628_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101754","volume":"36","author":"EM Curtis","year":"2022","unstructured":"Curtis EM, Dennison EM, Cooper C, Harvey NC (2022) Osteoporosis in 2022: care gaps to screening and personalised medicine. Best Pract Res Clin Rheumatol 36:101754","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7628_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C, Borgstr\u00f6m F (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16:82","journal-title":"Arch Osteoporos"},{"key":"7628_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.34172\/hpp.2023.05","volume":"13","author":"VK Chattu","year":"2023","unstructured":"Chattu VK, Singh B, Pattanshetty S, Reddy S (2023) Access to medicines through global health diplomacy. Health Promot Perspect 13:40\u201346","journal-title":"Health Promot Perspect"},{"key":"7628_CR5","unstructured":"(2021) Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev 2:e580-e592"},{"key":"7628_CR6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-011-1601-6","volume":"22","author":"C Cooper","year":"2011","unstructured":"Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277\u20131288","journal-title":"Osteoporos Int"},{"key":"7628_CR7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00198-015-3154-6","volume":"26","author":"A Oden","year":"2015","unstructured":"Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010\u20132040. Osteoporos Int 26:2243\u20132248","journal-title":"Osteoporos Int"},{"key":"7628_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00004148","volume":"7","author":"B Gullberg","year":"1997","unstructured":"Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407\u2013413","journal-title":"Osteoporos Int"},{"key":"7628_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"C Cooper","year":"1992","unstructured":"Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285\u2013289","journal-title":"Osteoporos Int"},{"key":"7628_CR10","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00198-022-06525-5","volume":"33","author":"S Hawley","year":"2022","unstructured":"Hawley S, Dela S, Burton A, Paruk F, Cassim B, Gregson CL (2022) Incidence and number of fragility fractures of the hip in South Africa: estimated projections from 2020 to 2050. Osteoporos Int 33:2575\u20132583","journal-title":"Osteoporos Int"},{"key":"7628_CR11","doi-asserted-by":"crossref","unstructured":"Wilson H, Manyanga T, Burton A, et al (2024) Age and sex specific incidence rates and future projections for hip fractures in Zimbabwe BMJ Global Health 10(1):e017365","DOI":"10.1136\/bmjgh-2024-017365"},{"key":"7628_CR12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.2301","volume":"29","author":"JA Kanis","year":"2014","unstructured":"Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926\u20131928","journal-title":"J Bone Miner Res"},{"key":"7628_CR13","doi-asserted-by":"crossref","unstructured":"WA P (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646\u2013650","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"7628_CR14","doi-asserted-by":"crossref","unstructured":"Klibanski A, Adams-Campbell L, Bassford T, Blair SN, Boden SD, Dickersin K, ... Russell WE\u00a0(2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785\u2013795","DOI":"10.1001\/jama.285.6.785"},{"key":"7628_CR15","unstructured":"WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization, Geneva"},{"key":"7628_CR16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137\u20131141","journal-title":"J Bone Miner Res"},{"key":"7628_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467\u2013475","journal-title":"Bone"},{"key":"7628_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468\u2013489","journal-title":"Osteoporos Int"},{"key":"7628_CR19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","volume":"20","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis JA, Oden A et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185\u20131194","journal-title":"JBone MinerRes"},{"key":"7628_CR20","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1359\/jbmr.1998.13.10.1587","volume":"13","author":"CE De Laet","year":"1998","unstructured":"De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res 13:1587\u20131593","journal-title":"J Bone Miner Res"},{"key":"7628_CR21","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jbmr.112","volume":"25","author":"L Langsetmo","year":"2010","unstructured":"Langsetmo L, Leslie WD, Zhou W et al (2010) Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. J Bone Miner Res 25:2108\u20132114","journal-title":"J Bone Miner Res"},{"key":"7628_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00223-024-01336-8","volume":"116","author":"JA Kanis","year":"2025","unstructured":"Kanis JA, Johansson H, Lorentzon M, Harvey NC, McCloskey EV (2025) Conflating the operational definition of osteoporosis with intervention thresholds. Calcif Tissue Int 116:22","journal-title":"Calcif Tissue Int"},{"key":"7628_CR23","unstructured":"FDA (1994) Food and Drug Administration Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drug Products, Food and Drug Administration, Rockville, MD"},{"key":"7628_CR24","unstructured":"CHMP (2006) Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. Ref CPMP\/EWP\/552\/95Rev.2, London, UK"},{"key":"7628_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-005-1984-3","volume":"17","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Abadie E, Delmas P et al (2006) Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporos Int 17:1\u20137","journal-title":"Osteoporos Int"},{"key":"7628_CR26","volume-title":"Guidelines for preclinical evaluation and clinical trials in osteoporosis","author":"WHO","year":"1998","unstructured":"WHO (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. World Health Organization, Geneva"},{"key":"7628_CR27","unstructured":"Agency PaMD (2022) Japan Ministry of Health, Japan"},{"key":"7628_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/jcem.85.1.6267","volume":"85","author":"RD Wasnich","year":"2000","unstructured":"Wasnich RD, Miller PD (2000) Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 85:231\u2013236","journal-title":"J Clin Endocrinol Metab"},{"key":"7628_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281\u2013289","journal-title":"Am J Med"},{"key":"7628_CR30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586\u20131592","journal-title":"J Clin Endocrinol Metab"},{"key":"7628_CR31","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","volume":"34","author":"ML Bouxsein","year":"2019","unstructured":"Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM (2019) Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34:632\u2013642","journal-title":"J Bone Miner Res"},{"key":"7628_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11657-022-01172-z","volume":"17","author":"NC Harvey","year":"2022","unstructured":"Harvey NC, Clegg PD, Dennison EM et al (2022) UKRI MRC national musculoskeletal ageing network: strategic prioritisation to increase healthy lifespan and minimise physical frailty. Arch Osteoporos 17:147","journal-title":"Arch Osteoporos"},{"key":"7628_CR33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1503\/cmaj.070234","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575\u2013580","journal-title":"CMAJ"},{"key":"7628_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/PL00004173","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W (2000) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11:120\u2013127","journal-title":"Osteoporos Int"},{"key":"7628_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S8756-3282(00)00238-6","volume":"26","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 26:387\u2013391","journal-title":"Bone"},{"key":"7628_CR36","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90:2787\u20132793","journal-title":"J Clin Endocrinol Metab"},{"key":"7628_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-012-9666-6","volume":"92","author":"A Od\u00e9n","year":"2013","unstructured":"Od\u00e9n A, McCloskey EV, Johansson H, Kanis JA (2013) Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int 92:42\u201349","journal-title":"Calcif Tissue Int"},{"key":"7628_CR38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989\u2013995","journal-title":"Osteoporos Int"},{"key":"7628_CR39","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, Epidemiology IOFWGo, Quality of L (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239\u20132256","journal-title":"Osteoporos Int"},{"key":"7628_CR40","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00198-020-05631-6","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Cooper C, Dawson-Hughes B, Harvey NC, Johansson H, Lorentzon M, McCloskey EV, Reginster JY, Rizzoli R (2020) FRAX and ethnicity. Osteoporos Int 31:2063\u20132067","journal-title":"Osteoporos Int"},{"key":"7628_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11657-021-00969-8","volume":"17","author":"C Willers","year":"2022","unstructured":"Willers C, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Borgstr\u00f6m F, Kanis JA (2022) Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos 17:23","journal-title":"Arch Osteoporos"},{"key":"7628_CR42","unstructured":"International Osteoporosis Foundation (2013) The Asia-Pacific Regional Audit: epidemiology, costs & burden of osteoporosis in 2013. Nyon, Switzerland"},{"key":"7628_CR43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229\u2013238","journal-title":"Osteoporos Int"},{"key":"7628_CR44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00198-015-3406-5","volume":"27","author":"E McCloskey","year":"2016","unstructured":"McCloskey E (2016) A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base. Osteoporos Int 27:417\u2013419","journal-title":"Osteoporos Int"},{"key":"7628_CR45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.113.004876","volume":"130","author":"Y Li","year":"2014","unstructured":"Li Y, Wei FF, Thijs L et al (2014) Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation 130:466\u2013474","journal-title":"Circulation"},{"key":"7628_CR46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40119-019-0144-3","volume":"8","author":"A de la Sierra","year":"2019","unstructured":"de la Sierra A (2019) New American and European hypertension guidelines, reconciling the differences. Cardiol Ther 8:157\u2013166","journal-title":"Cardiol Ther"},{"key":"7628_CR47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25","journal-title":"Arch Osteoporos"},{"key":"7628_CR48","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594","journal-title":"BMJ"},{"key":"7628_CR49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2020.07.009","volume":"143","author":"F Juchli","year":"2021","unstructured":"Juchli F, Zangger M, Schueck A, von Wolff M, Stute P (2021) Chronic non-communicable disease risk calculators - an overview, part I. Maturitas 143:25\u201335","journal-title":"Maturitas"},{"key":"7628_CR50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.maturitas.2020.10.003","volume":"143","author":"F Juchli","year":"2021","unstructured":"Juchli F, Zangger M, Schueck A, von Wolff M, Stute P (2021) Chronic non-communicable disease risk calculators - an overview, Part II. Maturitas 143:132\u2013144","journal-title":"Maturitas"},{"key":"7628_CR51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"7628_CR52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bone.2004.06.017","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029\u20131037","journal-title":"Bone"},{"key":"7628_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O, Oden A et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155\u2013162","journal-title":"Osteoporos Int"},{"key":"7628_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1734-y","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2004) Alcohol intake as a risk factor for fracture. Osteoporos Int\u00a016(7):737\u201342","journal-title":"Osteoporos Int"},{"key":"7628_CR55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jbmr.3331","volume":"33","author":"NC Harvey","year":"2018","unstructured":"Harvey NC, Oden A, Orwoll E et al (2018) Falls predict fractures independently of FRAX probability: a meta-analysis of the osteoporotic fractures in men (MrOS) study. J Bone Miner Res 33:510\u2013516","journal-title":"J Bone Miner Res"},{"key":"7628_CR56","unstructured":"Kanis J.A. on behalf of the WHO Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK"},{"key":"7628_CR57","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-207907","volume":"74","author":"A Marques","year":"2015","unstructured":"Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JA (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74:1958\u20131967","journal-title":"Ann Rheum Dis"},{"key":"7628_CR58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00198-019-04919-6","volume":"30","author":"C Beaudoin","year":"2019","unstructured":"Beaudoin C, Moore L, Gagn\u00e9 M, Bessette L, Ste-Marie LG, Brown JP, Jean S (2019) Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression. Osteoporos Int 30:721\u2013740","journal-title":"Osteoporos Int"},{"key":"7628_CR59","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jbmr.1956","volume":"28","author":"KH Rubin","year":"2013","unstructured":"Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28:1701\u20131717","journal-title":"J Bone Miner Res"},{"key":"7628_CR60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11657-024-01441-z","volume":"19","author":"B Cortet","year":"2024","unstructured":"Cortet B, Gua\u00f1abens N, Brandi ML, Siggelkow H (2024) Similarities and differences between European guidelines for the management of postmenopausal osteoporosis. Arch Osteoporos 19:84","journal-title":"Arch Osteoporos"},{"key":"7628_CR61","first-page":"12","volume":"122","author":"F Thomasius","year":"2025","unstructured":"Thomasius F, Kurth A, Baum E, Drey M, Maus U, Schmidmaier R (2025) Clinical practice guideline: the diagnosis and treatment of osteoporosis. Dtsch Arztebl Int 122:12\u201318","journal-title":"Dtsch Arztebl Int"},{"key":"7628_CR62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046","journal-title":"Osteoporos Int"},{"key":"7628_CR63","unstructured":"WFPS (2025) Falls guideline algorithm. World Falls Prevention Society"},{"key":"7628_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02219-9","author":"M Schini","year":"2023","unstructured":"Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV (2023) An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest\u00a047(3):501\u2013511","journal-title":"J Endocrinol Invest"},{"key":"7628_CR65","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-007-0362-8","volume":"18","author":"ND Nguyen","year":"2007","unstructured":"Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18:1109\u20131117","journal-title":"Osteoporos Int"},{"key":"7628_CR66","doi-asserted-by":"crossref","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ 344:e3427","journal-title":"BMJ"},{"key":"7628_CR67","doi-asserted-by":"crossref","first-page":"b4229","DOI":"10.1136\/bmj.b4229","volume":"339","author":"J Hippisley-Cox","year":"2009","unstructured":"Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFracture scores. BMJ 339:b4229","journal-title":"BMJ"},{"key":"7628_CR68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline G","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline G (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25","journal-title":"Arch Osteoporos"},{"key":"7628_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1747-2","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int\u00a023(1):75\u201385","journal-title":"Osteoporos Int"},{"key":"7628_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-011-9544-7","volume":"90","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX((R)) with and without bone mineral density. Calcif Tissue Int 90:1\u201313","journal-title":"Calcif Tissue Int"},{"key":"7628_CR71","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379:2407\u20132416","journal-title":"N Engl J Med"},{"key":"7628_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-019-05226-w","volume":"31","author":"T Merlijn","year":"2020","unstructured":"Merlijn T, Swart KMA, van der Horst HE, Netelenbos JC, Elders PJM (2020) Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Osteoporos Int 31:251\u2013257","journal-title":"Osteoporos Int"},{"key":"7628_CR73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jbmr.3411","volume":"33","author":"E McCloskey","year":"2018","unstructured":"McCloskey E, Johansson H, Harvey NC et al (2018) Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures-a post hoc analysis of the SCOOP study. J Bone Miner Res 33:1020\u20131026","journal-title":"J Bone Miner Res"},{"key":"7628_CR74","unstructured":"Nations U (2019) Decade of healthy ageing: action plan. United Nations,"},{"key":"7628_CR75","unstructured":"International Osteoporosis Foundation (2012) The Latin America Regional Audit: epidemiology, costs & burden of osteoporosis in 2012. Nyon, Switzerland"},{"key":"7628_CR76","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jbmr.2218","volume":"29","author":"G Ballane","year":"2014","unstructured":"Ballane G, Cauley JA, Luckey MM, Fuleihan Gel H (2014) Secular trends in hip fractures worldwide: opposing trends east versus west. J Bone Miner Res 29:1745\u20131755","journal-title":"J Bone Miner Res"},{"key":"7628_CR77","doi-asserted-by":"crossref","unstructured":"Ward KA, Madanhire T, Marenah K, Micklesfield LK, Gregson CL (2024) Disparities in fragility fracture and osteoporosis care in Africa. Lancet Diabetes Endocrinol 12(5):294\u2013296","DOI":"10.1016\/S2213-8587(24)00073-1"},{"key":"7628_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-023-00801-x","author":"KA Ward","year":"2023","unstructured":"Ward KA, Pearse CM, Madanhire T, Wade AN, Fabian J, Micklesfield LK, Gregson CL (2023) Disparities in the prevalence of osteoporosis and osteopenia in men and women living in sub-Saharan Africa, the UK, and the USA. Curr Osteoporos Rep 21(4):360\u2013371","journal-title":"Curr Osteoporos Rep"},{"key":"7628_CR79","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-019-0609-y","volume":"14","author":"SA Beshyah","year":"2019","unstructured":"Beshyah SA, Al-Saleh Y, El-Hajj Fuleihan G (2019) Management of osteoporosis in the Middle East and North Africa: a survey of physicians\u2019 perceptions and practices. Arch Osteoporos 14:60","journal-title":"Arch Osteoporos"},{"key":"7628_CR80","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00198-020-05435-8","volume":"31","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Westbury LD, Dennison EM et al (2020) Bone densitometry worldwide: a global survey by the ISCD and IOF. Osteoporos Int 31:1779\u20131786","journal-title":"Osteoporos Int"},{"key":"7628_CR81","unstructured":"International Osteoporosis Foundation (2011) The Middle East & Africa Regional Audit: epidemiology, costs & burden of osteoporosis in 2011. Nyon, Switzerland"},{"key":"7628_CR82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tripleo.2010.03.035","volume":"110","author":"K Horner","year":"2010","unstructured":"Horner K, Allen P, Graham J et al (2010) The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:243\u2013249","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"7628_CR83","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-023-06728-4","volume":"34","author":"A M\u00e9trailler","year":"2023","unstructured":"M\u00e9trailler A, Hans D, Lamy O, Gonzalez Rodriguez E, Shevroja E (2023) Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus study. Osteoporos Int 34:1401\u20131409","journal-title":"Osteoporos Int"},{"key":"7628_CR84","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1210\/jc.2014-4390","volume":"100","author":"WD Leslie","year":"2015","unstructured":"Leslie WD, Lix LM, Morin SN, Johansson H, Od\u00e9n A, McCloskey EV, Kanis JA (2015) Hip axis length is a FRAX- and bone density-independent risk factor for hip fracture in women. J Clin Endocrinol Metab 100:2063\u20132070","journal-title":"J Clin Endocrinol Metab"},{"key":"7628_CR85","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00198-022-06387-x","volume":"33","author":"L Johansson","year":"2022","unstructured":"Johansson L, Johansson H, Axelsson KF et al (2022) Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX. Osteoporos Int 33:1725\u20131738","journal-title":"Osteoporos Int"},{"key":"7628_CR86","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-024-07670-0","volume":"25","author":"B Lopez","year":"2024","unstructured":"Lopez B, Meertens R, Gundry M, Scott P, Crone MB, McWilliam R (2024) A comparison between IBEX bone health applied to digital radiographs and dual-energy x-ray absorptiometry at the distal-third and ultra-distal regions of the radius. BMC Musculoskelet Disord 25:575","journal-title":"BMC Musculoskelet Disord"},{"key":"7628_CR87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40520-024-02784-w","volume":"36","author":"NR Fuggle","year":"2024","unstructured":"Fuggle NR, Reginster JY, Al-Daghri N et al (2024) Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art. Aging Clin Exp Res 36:135","journal-title":"Aging Clin Exp Res"},{"key":"7628_CR88","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jbmr.4477","volume":"37","author":"M Jang","year":"2022","unstructured":"Jang M, Kim M, Bae SJ, Lee SH, Koh JM, Kim N (2022) Opportunistic osteoporosis screening using chest radiographs with deep learning: development and external validation with a cohort dataset. J Bone Miner Res 37:369\u2013377","journal-title":"J Bone Miner Res"},{"key":"7628_CR89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10916-023-02030-2","volume":"48","author":"DJ Tsai","year":"2024","unstructured":"Tsai DJ, Lin C, Lin CS, Lee CC, Wang CH, Fang WH (2024) Artificial intelligence-enabled chest X-ray classifies osteoporosis and identifies mortality risk. J Med Syst 48:12","journal-title":"J Med Syst"},{"key":"7628_CR90","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jocd.2015.01.001","volume":"18","author":"JY Huang","year":"2015","unstructured":"Huang JY, Song WZ, Zeng HR, Huang M, Wen QF (2015) Performance of the osteoporosis self-assessment tool for Asians (OSTA) in screening osteoporosis among middle-aged and old women in the Chengdu region of China. J Clin Densitom 18:539\u2013545","journal-title":"J Clin Densitom"},{"key":"7628_CR91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11657-022-01159-w","volume":"17","author":"K Agarwal","year":"2022","unstructured":"Agarwal K, Cherian KE, Kapoor N, Paul TV (2022) OSTA as a screening tool to predict osteoporosis in Indian postmenopausal women - a nationwide study. Arch Osteoporos 17:121","journal-title":"Arch Osteoporos"},{"key":"7628_CR92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.afos.2020.04.001","volume":"6","author":"M Chandran","year":"2020","unstructured":"Chandran M, Chin YA, Choo KS et al (2020) Comparison of the Osteoporosis Self-Assessment Tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: a discriminatory value analysis in a multi-ethnic female population in Southeast Asia. Osteoporos Sarcopenia 6:53\u201358","journal-title":"Osteoporos Sarcopenia"},{"key":"7628_CR93","unstructured":"International Osteoporosis Foundation (2022) LATAM Audit 2021: epidemiology, cost and impact of osteoporosis and fragility fractures in Latin America. Nyon, Switzerland"},{"key":"7628_CR94","doi-asserted-by":"crossref","unstructured":"Madanhire T, Breasail M, Mukwasi-Kahari C, Kowo-Nyakoko F, Ebeling PR, Ferrand RA, Ward KA, Gregson CL (2024) Prevalence of HIV-associated osteoporosis and fracture risk in mid-life women: a cross-sectional study in Zimbabwe. J Bone Miner Res 39(10):1464\u20131473","DOI":"10.1093\/jbmr\/zjae138"},{"key":"7628_CR95","doi-asserted-by":"crossref","first-page":"04082","DOI":"10.7189\/jogh.15.04082","volume":"15","author":"A Burton","year":"2025","unstructured":"Burton A, Manyanga T, Wilson H et al (2025) Challenges to fracture service availability and readiness provided by allopathic and traditional health providers: national surveys across The Gambia and Zimbabwe. J Glob Health 15:04082","journal-title":"J Glob Health"},{"key":"7628_CR96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.4715","volume":"38","author":"DJM Bergen","year":"2023","unstructured":"Bergen DJM, Maurizi A, Formosa MM et al (2023) High bone mass disorders: new insights from connecting the clinic and the bench. J Bone Miner Res 38:229\u2013247","journal-title":"J Bone Miner Res"},{"key":"7628_CR97","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"ES Siris","year":"2014","unstructured":"Siris ES, Adler R, Bilezikian J et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25:1439\u20131443","journal-title":"Osteoporos Int"},{"key":"7628_CR98","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/jbmr.2531","volume":"30","author":"JA Kanis","year":"2015","unstructured":"Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD (2015) Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res 30:1747\u20131753","journal-title":"J Bone Miner Res"},{"key":"7628_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-022-06567-9","volume":"34","author":"JA Kanis","year":"2023","unstructured":"Kanis JA, McCloskey EV, Harvey NC, Cooper C, Rizzoli R, Dawson-Hughes B, Maggi S, Reginster JY (2023) The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis. Osteoporos Int 34:1\u20139","journal-title":"Osteoporos Int"},{"key":"7628_CR100","unstructured":"Kanis JA (2007) Assessment of osteoporosis at the primary health care level. WHO Scientific Group Technical Report. World Health Organization, Geneva"},{"key":"7628_CR101","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-020-05804-3","volume":"32","author":"WF Lems","year":"2021","unstructured":"Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC, Cooper C, Javaid K, Ferrari S, Akesson KE (2021) Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int 32:399\u2013411","journal-title":"Osteoporos Int"},{"key":"7628_CR102","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00198-017-4341-4","volume":"29","author":"P Clark","year":"2018","unstructured":"Clark P, Denova-Guti\u00e9rrez E, Zerbini C et al (2018) FRAX-based intervention and assessment thresholds in seven Latin American countries. Osteoporos Int 29:707\u2013715","journal-title":"Osteoporos Int"},{"key":"7628_CR103","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11657-024-01397-0","volume":"19","author":"A Naseri","year":"2024","unstructured":"Naseri A, Bakhshayeshkaram M, Salehi S, Heydari ST, Dabbaghmanesh MH, Dabbaghmanesh MM (2024) FRAX-derived intervention and assessment thresholds for osteoporosis in ten Middle Eastern countries. Arch Osteoporos 19:41","journal-title":"Arch Osteoporos"},{"key":"7628_CR104","first-page":"802","volume":"2003","author":"F Calvo","year":"2003","unstructured":"Calvo F, Karras BT, Phillips R, Kimball AM, Wolf F (2003) Diagnoses, syndromes, and diseases: a knowledge representation problem. AMIA Annu Symp Proc 2003:802","journal-title":"AMIA Annu Symp Proc"},{"key":"7628_CR105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40520-022-02100-4","volume":"34","author":"EM Curtis","year":"2022","unstructured":"Curtis EM, Reginster JY, Al-Daghri N et al (2022) Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin Exp Res 34:695\u2013714","journal-title":"Aging Clin Exp Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:03:15Z","timestamp":1758747795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7628"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07628-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This Position Paper article contains no original data and thus issues of ethics, informed consent and patient confidentiality do not apply.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NC Harvey reports personal fees, consultancy, lecture fees and\/or honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Echolight, Consilient Healthcare, Theramex and Internis Pharma outside the submitted work. ML Brandi reports honoraria: Amgen, Ascendis, Bruno Farmaceutici, Calcilytix, Kyowa Kirin; Grants and\/or speaker: Alexion, Amgen, Amolyt, Bruno Farmaceutici, CoGeDi, Echolight, Gedeon Richter, Kyowa Kirin, Monte Rosa Therapeutics, UCB; Consultant: Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Enterabio, Kyowa Kirin, Personal Genomics, Septerna. C Campusano reports lecture fees and\/or honoraria from Faes farma, Novartis, Sandoz, Asofarma. M Chandran reports honoraria and consulting fees from Amgen Asia, Promedius. C Cooper reports personal fees, consultancy, lecture fees and\/or honoraria from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier and Takeda. M Lazaretti reports consultancy and lecture fees from Theramex, Sandoz, Astrazeneca, Mantecorp and Myralis. J Kanis is a director of Osteoporosis Research Ltd which maintains FRAX. E McCloskey reports personal fees, consultancy, lecture fees and\/or honoraria from Amgen, Fresenius Kabi, Theramex, UCB. Director, Osteoporosis Research Ltd. N Al-Daghri, C Beaudart, N Burlet, E Cavalier, B Dawson-Hughes, P Halbout, T Hough, R Matijevic, A Mithal, N Njeze, R Rizzoli, Y Saleh, K Ward report no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}